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Abstract 
 
The Molecular Chaperone Skp Reduces Client Protein Aggregation 
Under In Vivo-like Conditions 
 
Elizabeth H. Bogardus, M.A. 
The University of Texas at Austin, 2015 
 
Supervisor:  Jennifer A. Maynard 
 
Recombinant proteins form the basis of a vibrant biotechnology industry, acting 
as key players in therapeutics, reagents and diagnostics.1 However, multi-chain proteins 
are hard to produce efficiently.1 The yield of recombinant proteins can be improved by 
co-expression of folding factors with the target protein.2 Co-expression with folding 
factors has been met with some success.2 However, deeper knowledge about the folding 
factors and the ways in which they interact with each other will ultimately improve 
expression of proteins.  
The bacterial seventeen kilodalton protein (Skp) has been exploited to prevent 
aggregation of recombinant proteins in the bacterial periplasm.3 While the interactions 
between Skp and its client proteins have been studied in vitro, the more relevant in vivo 
interactions have not, nor has its relationship to the other protein folding molecules in the 
bacterial periplasm. In particular, the order of interactions between Skp and the Disulfide 
bond isomerases A and C (DsbA, DsbC) is unclear. To address this knowledge gap, the 
effect of Skp on substrate protein aggregation was observed under in vivo-like conditions 
 viii 
as a step towards analyzing the effect of Skp in vivo. The effect of Skp on aggregation 
was reduced under in vivo-like conditions as compared to dilute in vitro experiments. The 
order of interaction between Skp, DsbA and DsbC on a substrate protein was observed. In 
the first experiment, the effect of the combination of Skp with DsbA and Skp with DsbC 
on the aggregation of lysozyme was observed. The greatest reduction in the aggregation 
of lysozyme was due to the addition of Skp with either DsbA or DsbC. In the second 
experiment, the order of interaction between Skp, DsbA and DsbC was assayed but no 
clear conclusion could be drawn. These insights will contribute to the understanding of 
protein expression in the bacterial periplasm. 
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Chapter 1: Introduction 
Recombinant proteins are used as reagents in laboratories and as therapeutics.1 
Recombinant proteins with disulfide bonds are expressed in the oxidizing periplasmic 
space as the environment in this space favors the formation of disulfide bonds.1  Proteins 
destined for the periplasmic space are synthesized by ribosomes in the cytoplasm and are 
imported into the periplasmic space by the Sec translocon.3 The folding of proteins is 
rate-limited by proline isomerization and by the formation of correctly paired disulfide 
bonds.4 Proline isomerization is accelerated by peptidyl prolyl isomerases (PPIases), 
while the formation of correct disulfide bonds is facilitated by the disulfide bond (dsb) 
system.3 Chaperones promote productive folding by sequestering unfolded proteins, thus 
allowing the protein more time to fold.3 The yield of recombinant proteins can be 
improved by co-expression of folding factors with the target protein.2 The use of 
periplasmic folding factors has been met with some success, but deeper knowledge about 
the folding factors individually and the ways in which they interact with each other will 
ultimately improve expression of proteins.2 Basic research on protein folding will support 
research on protein folding diseases such as Alzheimers, Parkinson’s and Cystic Fibrosis.  
The bacterial Seventeen kilodalton protein (Skp) is a periplasmic holdase 
chaperone that prevents aggregation by sequestering unfolded proteins.5 Skp has been 
exploited to prevent aggregation of recombinant proteins such as whole immunoglobulins 
(IgGs) and antibody fragments when expressed in the bacterial periplasm.2 However, 
Entzminger et al. observed in 2012 that not all proteins interact with Skp and so Skp 
demonstrates client protein selectivity.5 The basis for Skp client selectivity has not been 
fully elucidated. Also the order of interaction of Skp and the disulfide bond (dsb) 
formation system with substrate proteins has yet to be determined. The basis of Skp client 
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selectivity was further investigated in this work. The effect of Skp on substrate protein 
aggregation was observed under in vivo-like conditions as a step towards analyzing the 
effect of Skp in vivo. The order of interaction between Skp, DsbA and DsbC on a 
substrate protein was also observed. Further knowledge about Skp individually and 
interacting with other folding factors ultimately improve the production of soluble 
proteins.  
VITAL OUTER MEMBRANE PROTEINS FOLD IN THE PERIPLASMIC SPACE 
Recombinant proteins expressed in the periplasmic space of Escherichia coli take 
advantage of folding factors that help host proteins fold. The periplasmic space exists 
between the inner and outer membranes of E. coli.3 Vital processes such as the 
transportation of nutrients, the rotation of flagella, and cell envelope repair occur in the 
periplasmic space.3 As a result, 300 unique types of proteins can be found in this space.3 
These proteins fall into the broad classes of outer membrane proteins (OMPs), inner 
membrane proteins, soluble proteins and virulence factors. Outer membrane are an 
important class of proteins that perform a variety of functions.6 For example, some 
OMPs, such as PhoE and LamB, allow the transport of nutrients into the cell.6 Other 
OMPs, such as OmpT and phospholipase A, are enzymes.6 The beta-barrel integral OMPs 
are especially well characterized.7 The beta barrel of OMPs may be formed from 8-24 
beta-strands and structure may contain a periplasmic domain.7 The beta-barrel of OMPs 
spans the lipid bilayer.7 Amino acids on the beta-strands that contact the hydrophobic 
tails of the lipid bilayer are hydrophobic.7 Sections of the OMP protein sequence cross 
through the lipid bilayer are called transmembrane sequences (TMS).7  
OMPs are inserted into the outer membrane by the BAM insertion complex.3 
OMPs are synthesized by ribosomes in the cytoplasmic space and cross the inner 
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membrane into the periplasmic space via the SecYEG translocon.3 The SecYEG 
translocon is a channel embedded in the inner membrane.3 Recombinant proteins that are 
destined for the periplasmic space contain a N-terminal signal sequence that is recognized 
by the SecYEG translocon.3 The proteins are threaded linearly through SecYEG 
translocon and the signal sequence is cleaved upon arrival in the periplasmic space.3 
Hydrophobic residues in the peptide chain are exposed when the linearized protein exits 
the Sec translocon.3 The hydrophobic residues on the unfolded peptide chain are attracted 
to the hydrophobic residues is other unfolded proteins thus causing aggregation.3  
PERIPLASMIC FOLDING FACTORS AID IN SURVIVAL DURING HARSH CONDITIONS 
Recombinant proteins expressed in the periplasmic space of E. coli take 
advantage of folding factors that help the cell survive in harsh environments.8, 9 Cells 
respond to changes in environmental conditions through stress responses.8, 9 Harsh 
environmental conditions such as high heat and variances in pH can denature proteins.8, 9 
The envelope stress response is elicited by the presence of unfolded proteins in the 
periplasmic space.8, 9 Sigma factor σE (σ24) upregulates the expression of periplasmic 
proteases, PPIases and molecular chaperones to assist in protein refolding and cleavage.8, 
9 Sigma factor σE is released by the detection of unfolded OMPs.8, 9 Sigma factor σE is 
bound to RseA at the inner membrane on the cytoplasmic side under normal 
physiological conditions.8, 9 RseA is an integral protein that contains a periplasmic and a 
cytoplasmic domain connected by one transmembrane region.9 Under normal conditions 
RseB inhibits σE by binding to RseA.9 OMP proteins contain a YxF sequence on the c-
terminal of that is normally buried when an OMP is properly folded but it is exposed 
when the OMP protein has unfolded.9 A protease called DegS binds to YxF sequences 
when they are exposed and becomes activated.9 DegS and RseP trigger a proteolytic 
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cascade that cleaves RseA leaving one cytoplasmic domain of RseA with σE.9 Protease 
ClpXP degrades the cytoplasmic domain of RseA releasing σE.9 The binding of sigma 
factor σE to RNA polymerase drives the upregulation of folding factors such as FkpA and 
DegP.8, 9 Conditions that denature proteins, such as heat or ethanol, induce this envelope 
stress response.8, 9  
The two-component system of CpxA/CpxR responds to misfolded proteins, 
starvation, inner membrane alteration, and changes in pH.8, 10 CpxA is a sensor histidine 
kinase and CpxR is a cytoplasmic response regulator CpxR.8, 10 The kinase 
phosphorylates CpxR, which allows CpxR to bind to DNA and increase the expression of 
150 proteins.10 These proteins assist in the refolding of unfolded proteins and degradation 
of aggregates.8, 10 These stress responses prevent the aggregation of proteins in the 
periplasmic space so that the cell can survive harsh conditions.  
PERIPLASMIC FOLDING FACTORS PROMOTING FOLDING AND REDUCING AGGREGATION 
The periplasmic space contains folding factors such as molecular chaperones, 
peptidyl prolyl isomerases (PPIases), disulfide bond isomerases that help the cell survive 
in harsh environments.3 Protein aggregation in the periplasmic space is reduced through 
two redundant pathways.3 The first pathway includes the chaperone and peptidyl-prolyl 
cis-trans isomerase (PPIase) SurA.3 The second pathway includes the chaperone Skp and 
the protease DegP.3 The two redundant pathways exist to ensure that proteins fold.3 
Mutation of surA results in hypersensitivity to EDTA, SDS, and bile salts.3 This 
phenotype results because the outer membrane density is decreased due to decreased 
numbers of properly folded OMPs in surA mutant cells.3 Mutation of skp or degP resulted 
in decreased amounts of LamB, OmpA, OmpC, OmpF.3 Double mutants of skp surA and 
skp surA are lethal, indicating that at least one pathway is necessary for survival.11 These 
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results established the notion that the two pathways were redundant.3 Deletion of surA 
resulted in a more significant change in phenotype the deletion of skp or degP.3 It was 
concluded from these results that SurA is the primary pathway for folding in the 
periplasmic space.12 Skp and DegP comprise the secondary pathway, which rescues 
unfolded proteins that are not folded by the primary pathway.12 The collective action of 
the chaperones in the periplasmic space is referred to as the chaperone network.3 
Substrate proteins may be able to interact with many different chaperones.3 Substrate 
proteins that are dependent on a specific chaperone cannot fold productively without that 
specific chaperone.3  
SurA, Skp, DegP, FkpA, DsbA, and DsbC are periplasmic folding factors that 
have exploited to improve the production of recombinant proteins.2 A brief introduction 
to each factor is given here in order to explain how these factors improve recombinant 
protein folding. For a comprehensive review on periplasmic folding factors, read 
“Folding mechanisms of periplasmic proteins” by Camille Goemans et al.3  
SurA is both a chaperone and a peptidyl-prolyl cis-trans isomerase (PPIase).3, 13 
The structure of SurA contains four domains.3, 13 The domains include a N-terminal 
domain, two parvulin-like PPIase domains and a C-terminal domain.3, 13 Only the second 
PPIase domain is functional.3 The first PPIase, the N-terminal, and the C-terminal 
domains form the core of the protein where chaperone activity occurs.3 The second 
PPIase is connected to the chaperone core by two long peptide chains.3 SurA recognizes 
Ar-X-Ar motif in unfolded OMPs and is the primary chaperone for OMP folding.3  
Seventeen kilodalton protein (Skp) is a periplasmic chaperone that prevents 
aggregation by sequestering unfolded proteins in its cage-like interior.5 The native 
structure of Skp is homotrimeric and is comprised of three 17kDa monomers.14 Each 
monomer contains two alpha helices and a beta sheet region.14 The two alpha helices are 
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bent at an angle to form an arch.14 The three monomers are loosely associated by a ring at 
the base formed from the beta sheet domains.14 The final structure is a claw with three 
prongs.14 Skp interacts with the linear periplasmic proteins immediately after they have 
crossed the inner membrane via the Sec translocon.3  The unfolded substrate protein is 
inserted into the claw-like interior of Skp.3  
DegP functions as a chaperone at low temperatures, but it can operate as a solely 
as a protease at high temperatures.3, 8 DegP exists as a disordered, inactive homohexamer 
composed of two trimer rings.3 Binding of unfolded substrate protein to PDZ domains 
and the active site initates the formation of a cage of 4-8 trimers.3 This provides a large 
cavity to house unfolded proteins.3 Binding of substrate activates the serine protease 
catalytic site for the degradation of proteins.3  
FkpA is a chaperone and PPIase that assists protein folding in the periplasmic 
space.3, 8 FkpA has been shown to assist Skp in the folding of LptD.3 Double mutants of 
skp and fkpA results a loss of membrane integrity due to decreases in LptD.3 FkpA is also 
upregulated by the envelope stress response.8  
Correct disulfide bond formation is facilitated by the disulfide bond (dsb) 
system.8, 15 Disulfide bonds are introduced into proteins by disulfide oxidoreductase A 
(DsbA).8, 15 DsbA forms disulfide bonds by transferring two electrons stored in the 
disulfide bond in DsbA to target proteins.8, 15 Reduced DsbA is reoxidized by DsbB.8, 15 
DsbA can only create disulfide bonds between consecutive cysteines.8, 15 Some proteins 
contain non-consecutive disulfide bonds.8, 15 Isomerization of incorrect disulfide bond 
pairing is catalyzed by DsbC. DsbC is regenerated by inner membrane protein DsbD.8, 15  
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CHAPERONES ENHANCE RECOMBINANT PROTEIN YIELD 
This basic knowledge about periplasmic folding factors has been exploited to 
increase the yield of periplasmic proteins.2 In 1998 Hendrick Bothmann and Andreas 
Pluckthun selected for periplasmic factors that could improve the folding of a single 
chain antibody fragment scFv) via phage display.16 The structure of scFv includes the 
variable heavy (VH) and variable light (VL) domains connected by a flexible linker 
glycine serine linker (Gly4Ser)3.17 Full-length antibodies are typically produced in 
mammalian cell lines.17 ScFvs on average are one fifth of the size of full-length 
antibodies and so scFvs can be produced in E. coli with ease.17 ScFvs retain antigen 
binding specificity but lack Fc effector constant domains.17 The variable domains of the 
scFv can be engineered to improve aspects such as binding affinity or stability via phage 
display.16 A library of phage displaying scFv variants is selected for over multiple 
generations.16 The selected scFv variants contain advantageous mutations that improved 
their ability to surpass selection pressures.16  
Bothmann and Pluckthun selected for periplasmic factors that could improve the 
folding of a scFv by digesting genomic E. coli DNA into 1-6 kb pieces and displaying the 
fragments on phage with poorly folding 4-4-20 scFv.16 Selected phage were hypothesized 
to contain a fragment of E. coli DNA that led to the expression of a folding factor that 
may have assisted in the folding of the 4-4-20 scFv.16 Skp was also shown to improve the 
folding of soluble 4-4-20 as shown by antigen binding ELISA.16 The selected phage 
contained a 990 bp sequence insert.16 This insert included the E. coli skp gene with a 
truncated sequence of the lpxD (firA) gene.16 The ELISA result stayed the same when the 
lpxD gene was removed, indicating that the folding factor was due to skp, not firA.16  
Skp has been exploited to improve the folding of many types of target proteins 
since then.2 Expression of Skp was shown to improve the folding of scAb to pathogen 
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Brucella melitensis in phage display in 2003 by Andrew Hayhurst et al.18 Skp has aided 
in the expression of single-chain alpha beta T-cell receptors.19 In 2008 Lin et al. 
improved the yield of Fab59 100 fold through co-expression with Skp combined with 
codon optimization and adjustment to the promoter sequence.20 Skp co-expresion also 
improves cell-surface by reducing extracytoplasmic stress.21 Mitochondria-targeted Skp 
has even been used to improve the folding of the YadA autotransporter bacterial in 
yeast.22  
Co-expression of Skp with additional of folding factors has become increasingly 
popular as our knowledge of the chaperone network has expanded.2 In 2001 Georgiou et 
al. improved the expression of Fab antibody fragment in the cytoplasm of E. coli trxB gor 
mutants by adding Skp in addition to GroEL/S and TF and DsbC without a leader 
sequence.1 In 2009 Georgiou improved the expression of human sialyltransferase 
ST6GalNAcl by co-expressing with Skp, TF, DnaK, DnaJ, and GroEL/ES. Co-expression 
with an additional folding factor can increase folding over folding due to Skp alone.23  
Plasmids can now co-express six to seven folding partners with the target 
protein.17 It was hypothesized by Sonoda et al. in 2011 that cocktails of multiple 
chaperones could be used to improve yield of recombinant proteins.17 Anti-bovine 
ribonuclease A scFv 3A21 was co-expressed with sets of cytoplasmic and periplasmic 
chaperones.17 Cytoplasmic chaperones co-expressed with the scFv included GroEL/ES, 
DnaK/DnaJ/GrpE, TF, and SecB.17 Periplasmic chaperones co-expressed with the scFv 
included Skp and FkpA.17 Chaperones did increase binding activity in all fractions as 
shown by ELISA and Western Blot.17 The periplasmic chaperone set improved the 
binding activity of the scFv, but the cytoplasmic chaperone set did not have an effect.17 
Skp co-expression resulted in higher binding activity of the folded scFv than when FkpA 
was added.17 These results demonstrated that generic cocktails of multiple chaperones are 
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not effective.17 Further knowledge about the folding factors individually and in 
combination is needed in order to optimize protein production yields through the addition 
of folding factors.  
While co-expression of Skp with target proteins dramatically increased the yield 
of the 4-4-20 scFv, it has been shown to be ineffective for some soluble proteins.5 
Entzminger et al. demonstrated in 2012 that soluble proteins exhibit varying sensitivities 
to Skp.5 Three single chain variable fragments (scFvs) known to have varying sensitivies 
to Skp were observed.5 The scFvs observed included ovalbumin peptide-MHC specific 
DO11.10 single-chain T cell receptor, 14B7 scFv specific to Protective Antigen and 4-4-
20 scFv.5  
Improvements in folding of the scFvs due to the addition of Skp was assessed as 
the scFvs were displayed on phage and expressed as soluble proteins.5 Increases in folded 
scFv during phage display were monitored by phage ELISA.5 The ELISA signal 
increased by significantly increased when Skp was co-expressed with 4-4-20 scFv.5 A 
moderate increase was detected when Skp was co-expressed with 14B7, but a decrease 
was observed for DO11.10.5 The impact of Skp on the folding of the scFvs expressed as 
soluble proteins was observed by western blot.5 The soluble and insoluble fractions were 
compared for each scFv.5 The level of scFv expressed in the soluble fraction over the 
insoluble fraction increased for 4-4-20 and 14B7 scFvs when Skp was co-expressed.5 Skp 
co-expression did not alter the level of soluble protein expressed for DO11.10.5 The 
DO11.10 scFv was determined to be Skp insensitive, the 14B7 scFv was determined to be 
somewhat Skp insensitive and 4-4-20 scFv was determined to be Skp dependent.5 Thus, it 
was demonstrated that soluble proteins exhibit varying sensitivities to Skp.5  
The knockdown of Skp was determined by Chen and Henning in 1996 to result in 
a decrease in the number of OMPs in the outer membrane.24 Missiakas and Raina 
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observed an increase in DegP in skp knockdowns, which suggested to them that the σE 
response was induced.24 This led Ute Schafer, Konstanze Beck and Matthias Muller to 
hypothesize in 1999 that proteins must be aggregated in the periplasmic space.24 Troy 
Walton and Marcelo Sousa observed the impact of the addition of Skp on the aggregation 
of denatured lysozyme in 2004.24 Lysozyme was denatured in urea and then rapidly 
diluted to a final concentration of 2µM.24 Lysozyme was diluted into buffer or solutions 
with or without varying concentrations of Skp.24 The absorbance was measured at 360nm, 
which is the wavelength of tryptophan emission.5 Tryptophan residues are buried in 
folded proteins. An increase in tryptophan absorbance is expected to occur when proteins 
are unfolded.5 Unfolded proteins aggregate, so an increase in absorbance at 360nm 
indicates an increase in aggregation.5 Walton and Sousa observed that the addition of Skp 
decreased absorbance, which indicates a decrease in aggregation.24  
Entzminger et al. observed the effect of Skp on the aggregation of soluble scFvs 
with varying Skp sensitivity using the aggregation assay developed by Walton and 
Sousa.5 The impact of Skp on scFv folding was assayed by denaturing the scFvs over 6 
hours in aggregation denaturation buffer (8M urea and 50mM DTT in HBS at pH 7.4) at 
a concentration of 100µM.5 The scFvs were diluted 100 fold into HBS (10mM HEPES, 
150 mM NaCl, pH 7.4) with and without maltose binding protein (MBP) or Skp at 1, 3, 
and 6µM.5 Aggregation was observed at 360nm over 30 minutes.5 The aggregation of 
Skp-sensitive scFvs decreased as the concentration of Skp increased.5 Addition of Skp to 
Skp-insensitive proteins did not reduce the aggregation of scFvs.5 The impact of Skp on 
scFv folding was also observed.5 However, it was determined that Skp did not have an 
impact on folding.5 This supported the conclusion that Skp acts as a holdase chaperone 
and not a foldase chaperone.5  
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The mechanism of interaction between Skp and substrate proteins has not been 
determined. Entzminger et al. postulated that Skp preferentially interacts with proteins 
containing a folding intermediate.5 Folding intermediates of the scFvs were probed 
through stability tests.5 First, stability in denaturant was assayed.5 The scFvs were 
denatured in varying concentrations of urea.5 Tryptophan fluorescence was observed. 
Unfolding occurs at 323nm for DO11.10 and 360nm for 14B7.5 The excitation 
wavelength was 280nm, and emission wavelengths of 310-380nm were recorded.5  
DO11.10 was determined not to have an intermediate, but 14B7 scFv did have one 
intermediate.5 The 4-4-20 scFv could not be analyzed as it was poorly soluble. Secondly, 
thermal stability was determined by incubating 10µM of scFvs with 1µL of 1:1000 Sypro 
Orange at temperatures ranging from 20-90°C.5 No conclusive result was derived through 
thermal stability testing.5 Thus it was demonstrated that Skp sensitive proteins contained 
a stable folding intermediate in vitro.5  
RESEARCH GOALS 
The basis of Skp client selectivity was further investigated in this work. The effect 
of Skp on substrate protein aggregation was observed under in vivo-like conditions as a 
step towards analyzing the effect of Skp in vivo. The individual role of Skp will be 
explored in Chapter 2. Also, the order of interaction of Skp and the disulfide bond (dsb) 
formation system with substrate proteins has yet to be determined. The order of 
interaction between Skp, DsbA and DsbC on a substrate protein was observed. The role 
of Skp with other periplasmic folding factors will be explored in Chapter 3. Further 
knowledge about the role of Skp individually and with other periplasmic folding factors 
will ultimately improve the production of soluble proteins. 
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Chapter 2: Macromolecular Crowding 
INTRODUCTION 
Skp improves the yield of proteins in vivo.2 Entzminger et al. demonstrated that 
Skp decreases the aggregation of Skp-sensitive proteins in vitro.5 The aggregation assay 
utilized was conducted under dilute conditions.25 Dilute in vitro experiments typically 
contain 1-10 gl-1 of macromolecules.25 In reality, cell interiors are crowded with 
macromolecules.25 The cell interior is estimated to be up to 30% crowded by 
macromolecules (300 gl-1).25 A concentrated solution refers to a solution with a large 
number of molecules of a single species in a specified volume, whereas a crowded 
solution is a solution containing different macromolecules present at large numbers in a 
specified volume.25 Crowding refers to the to the volume excluded by macromolecules.25 
Thermodynamic equilibrium measurements and reaction rates in vivo can differ by orders 
of magnitude from values obtained in vitro.25 Protein folding alters the available volume 
so it is apropos to observe Skp under in vivo-like conditions that approximate the degree 
of crowding in the cell. The effect of Skp on substrate protein aggregation was observed 
under in vivo-like conditions as a step towards elucidating the basis for Skp client 
selectivity in vivo. 
In vivo-like conditions can be achieved by adding high concentrations of a 
crowding agent to in vitro experiments.25 Successful crowding agents are globular, 
transparent and inert while have low viscosity. Popular crowding agents include Ficoll, 
Dextran, PEG, and sucrose.25 Ficoll 70 (Sigma) was chosen for this investigation as it 
fulfills the criteria of a successful crowding agent and also behaves as a rigid sphere.25  
The effect of Skp on the aggregation of lysozyme in a crowded in vivo-like 
environment was observed. Proteins with a high degree of purity were generated for use 
in subsequent experiments. Next, the lysozyme aggregation assay from Entzminger et al. 
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was replicated as a control experiment.5 Then the lysozyme aggregation assay was 
performed under in vivo-like conditions with varying percentages of Ficoll 70. Lastly, the 
lysozyme aggregation assay was performed under in vivo-like conditions with varying 
percentages of Ficoll 70 with the addition of Skp. Knowledge about the effect of Skp on 
aggregation under in-vivo like conditions will be the first step towards elucidating the 
basis for Skp client selectivity in vivo. 
MATERIALS AND METHODS 
Protein Purification  
Soluble Skp protein was expressed in the cytoplasmic space of E. coli as outlined 
in Entzminger et al.5 The skp gene without a leader sequence was previously cloned into 
a pET100D-TopoTA (Invitrogen) plasmid containing an n-terminal hexahistidine tag to 
facilitate protein expression in BL21(DE3) cells.5 Cells were grown in Terrific Broth with 
200 µg/mL ampicillin by shaking at 225rpm at 37°C until an OD600 of 0.6 was reached. 
Expression of Skp was induced by adding 1mM isopropyl β-D-1-thiogalactopyranoside 
(IPTG) and cells were grown for 5 hours with shaking at 225rpm at 25°C. The cells were 
pelleted and resuspended in French Press Buffer (25 mM HBS pH 7.4, 500 mM NaCl, 40 
mM Imidazole). Cells were lysed by passing the cells through the French Press (Thermo 
FA-078A) at 1500 psi pressure in a 35mL French Press cell (Thermo FA-032). Cellular 
debris was pelleted and the supernatant containing Skp protein was dialyzed overnight. 
The protein was eluted by Ni2+ immobilized metal affinity chromatography (IMAC). The 
eluted protein was purified in a second step through Superdex S75 or S200 size exclusion 
chromatography (SEC) columns operating on the AKTA FPLC system (GE Healthcare). 
The running buffer was HBS (pH 7.4). The SEC columns were standardized with 
proteins with a broad range of molecular weights (GE Healthcare, Sigma). The molecular 
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weight of eluted proteins can be determined relative to the molecular weight standards. 
The molecular weight of the eluted protein was confirmed by 12% SDS-PAGE. The 
concentrations of protein samples were determined by BCA Assay (Pierce). Lyophilized 
Bovine Serum Albumin (BSA, 2mg/mL) was used as a standard.  
Soluble Maltose Binding Protein (MBP) was expressed in the periplasmic space 
of E. coli as outlined in Entzminger et al.5 The MBP gene was previously cloned into a 
pAK400 plasmid with a n-terminal hexahistidine tag in BL21 (DE3) cells. Cells were 
grown in a starter culture of 2mL TB with 34µg/mL Cloramphenicol with shaking at 
225rpm at 37°C until an OD600 0.5 was exactly reached. Cells were grown in Terrific 
Broth with 200 µg/mL ampicillin by shaking at 225rpm at 37°C until an OD600 of 0.6 was 
reached. This starter culture was used to inoculate 250mL TB containing 34µg/mL 
Cloramphenicol. Cells were grown overnight with shaking at 225rpm at 37°C. The media 
was exchanged for 250mL of fresh TB with 34µg/mL Chloramphenicol. The cells were 
allowed to recover for 1 hour at 25°C and then expression of MBP was induced by 
adding a final concentration of 1mM IPTG. The cells were grown for 5 hours with 
shaking at 225rpm at 25°C. The cells were harvested and lysed by osmotic shock. Cells 
were resuspended in 10 mL sucrose solution (0.75M sucrose, 0.1M Tris, pH 8.0) and 
transferred into four 50mL centrifuge tubes. Additionally 10mL sucrose solution was 
added to each tube along with 250mL of 10mg/mL lysozyme in sucrose solution and 
10mL of 1mM EDTA (pH 8.0). The cells were incubated with rotation at 4C for 20-60 
minutes. Then, 0.5mL Magnesium Chloride (MgCl2) was added to each tube. The cells 
were incubated with rotation at 4C for 10 minutes. Cellular debris was pelleted and the 
supernatant containing MBP protein was dialyzed overnight. The protein was eluted by 
Ni2+ immobilized metal affinity chromatography (IMAC). The eluted protein was purified 
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columns operating on the AKTA FPLC system (GE Healthcare). The identify of the 
purified protein was characterized by 12% SDS-PAGE and the quantity of protein 
produced was determined by BCA Assay. 
Aggregation Assay 
The aggregation of lysozyme was replicated as proscribed by Entzminger et al.5 
Lysozyme was equilibrated in denaturation buffer (8M urea, 50mM, pH 7.4) for 6 hours 
at a concentration of 100µM. Denatured lysozyme was rapidly diluted 100 fold into HBS 
(10mM HEPES, 150mM NaCl, pH 7.4) solutions alone or with MBP or Skp in varying 
concentrations of Ficoll 70 crowding agent (0-30%). Lysozyme in denaturation buffer 
was added to the wells of a black, clear bottom 96-well Costar plate. The HBS solution 
with or without MBP or Skp in varying concentrations of Ficoll 70 crowding agent was 
pipetted into the denatured lysozyme solution. The absorbance at 360nm was detected at 
10s intervals over 30 minutes at room temperature with a SpectraMax M5. Experiments 
were replicated in triplicate. The background absorbance was subtracted from the average 
of the three replicates. The curves were normalized by dividing by the largest difference 
in absorbance. The error bars indicate the standard deviation of three replicates.  
RESULTS  
The proteins used in subsequent experiments in this study had a high degree of 
purity as determined by size exclusion chromatography (SEC) and sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Skp was expressed in the 
cytoplasmic space, purified first by IMAC chromatography and was purified next by 
SEC. The expected molecular weight of native trimeric Skp with a his-tag is estimated 
from the sequence to be 70,440 Da. A peak in the absorbance at 280nm is expected to 
occur between the Conalbumin (75kDa, 9.015mL) and Albumin (66kDa, 9.051mL) 
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standard elution volumes. A peak was detected in this elution volume range as shown in 
Figure 2.1, confirming the identity of the produced protein. Skp does not contain any 
tryptophan or cysteine residues, so the absorbance at 280nm is low even a total of 1.42mg 
of trimeric Skp was purified.  
The purity of the protein was also confirmed by gel electrophoresis on a 12% 
SDS-Polyacrylamide gel as shown in Figure 2.2. A ladder (NEB Pre-stained Protein 
Marker, Broad Range) is shown in lane 4. Skp is expected to be monomeric under 
reducing conditions. The molecular weight of monomeric Skp containing a his tag is 
expected to be 25kDa. The protein samples in lanes 2,3,5-15 migrated as far as the 25kDa 
marker. This further confirmed that Skp was produced. A single band is observed in lane 
of protein samples indicating that the protein was pure. A BCA Assay confirmed that 
sufficient quantities of protein were produced in order to proceed.  
MBP was expressed in the periplasmic space, purified first by IMAC 
chromatography and was purified next by SEC. MBP is natively found as a monomer. 
The expected molecular weight of MBP containing a his tag is estimated from the 
sequence to be 44,500 Da. A peak in the absorbance at 280nm is expected to occur 
between the Albumin (66kDa, 9.051mL) and Ovalbumin (44kDa, 9.633mL) standard 
elution volumes. A peak was detected in this elution volume range as shown in Figure 
2.3, confirming the identity of the produced protein.  
The purity of the protein was also confirmed by gel electrophoresis on a 12% 
SDS-Polyacrylamide gel as shown in Figure 2.4. A ladder (NEB Pre-stained Protein 
Marker, Broad Range) is shown in lane 3. The molecular weight of monomeric MBP 
with a his tag is expected to be 46,000 Da. The protein samples in lanes 4-15 migrated as 
far as the 46 kDa marker. This further confirmed that MBP was produced. A single band 
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is observed in lane of protein samples indicating that the protein was pure. A BCA Assay 
confirmed that sufficient quantities of protein were produced in order to proceed. 
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Figure 2.1: Skp was produced as shown by size exclusion chromatography on a GE 
Healthcare Superdex S75 column on the AKTA FPLC system. The 
molecular weight of trimeric Skp is 70kDa. Trimeric Skp eluted between 
9.015-9.510mL. The third peak from the left corresponds to a total of 
1.42mg of trimeric Skp.  
 
Figure 2.2: Recombinant Skp preparations exhibited a high degree of purity. Different 
fractions from a purification run are shown, separated on a 12% SDS-Poly 
Acrylamide Gel. Lanes reflect different fractions collected including the 
flowthrough from the IMAC column and those eluted off an S75 size 
exclusion chromatography column on an Akta FPLC. The molecular weight 
of monomeric Skp with a his tag is expected to be 25kDa. The protein 
samples in lanes 2,3,5-15 migrated as far as the 25kDa marker. This further 
confirmed that Skp was produced. A single band is observed indicating that 
the preparations were pure. 
Lanes 1. SKP_	  Flow	  through	  
2.      SKP_A6 3. SKP_A7	  4. Ladder	  5. SKP_A8	  6. SKP_A9	  7. SKP_A10	  8. SKP_A11	  9. SKP_A12	  
 
Lanes 10. SKP_B12	  11. SKP_B11	  12. SKP_B10	  13. SKP_B9	  14. SKP_B8	  15. SKP_B7	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Figure 2.3: MBP was produced as shown by size exclusion chromatography on a GE 
Healthcare Superdex S75 column on the AKTA FPLC system. The 
molecular weight of monomeric MBP is 44kDa. Monomeric MBP eluted 
between 9.633-11.122mL. The peak from the left corresponds to a total of 
5.83mg of MBP.  
 
Figure 2.4: Recombinant MBP preparations exhibited a high degree of purity. Different 
fractions from a purification run are shown, separated on a 12% SDS-Poly 
Acrylamide Gel. Lanes reflect different fractions collected including the 
flowthrough from the IMAC column and those eluted off an S75 size 
exclusion chromatography column on an Akta FPLC. The molecular weight 
of monomeric MBP with a hist tag is 46kDa. The protein samples migrated 
as far as the 46kDa marker. This further confirmed that MBP was produced. 
A single band is observed indicating that the preparations were pure. 
Lanes	   
1. Ladder 
2. MBP_Lysate 
3. MBP_Flow through 
4. MBP_A6 
5. MBP_A7 
6. MBP_A8 
7. MBP_A9 
8. MBP_A10 
9. MBP_A11 
Lanes	   
10. MBP_A12 
11. MBP_B12 
12. MBP_B11 
13. MBP_B10 
14. MBP_B9 
15. MBP_B8 
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Figure 2.5: Skp reduces the aggregation of proteins in vitro as demonstrated in a 
lysozyme aggregation assay. Denatured lysozyme was added to solutions 
containing HBS, MBP (1µM) or Skp (1 or 2µM). MBP does not exhibit 
chaperone activity, so it was used as a negative control. Absorbance does 
not decrease when MBP was added indicating that MBP does not reduce the 
aggregation of proteins. Absorbance was reduced proportionally with the 
addition of Skp indicating that Skp does reduce aggregation. The error bars 
represent the standard deviation of three replicates. 
The Lysozyme Aggregation Assay from Entzminger et al. was replicated as a 
control experiment.5 Lysozyme was rapidly diluted into HBS alone or with 1µM MBP or 
Skp (1-2µM) as shown in Figure 2.5. Lysozyme contains hydrophobic residues that are 
exposed when the protein is denatured.5 Unfolded lysozyme proteins are expected to 
aggregate.5 Absorbance at 360nm increased over time when lysozyme was rapidly diluted 
into HBS solution. The aggregation of lysozyme increased over time in HBS. MBP does 
not exhibit chaperone activity, and so it was used a negative control. Absorbance at 
360nm increased over time when lysozyme was rapidly diluted into HBS with 1µM 
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MBP. The aggregation of lysozyme also increased over time in HBS with 1µM MBP as 
expected. Skp is expected to reduce aggregation. A decrease absorbance at 360nm over 
time indicates that Skp reduced aggregation. The absorbance at 360nm decreased over 
time when Skp was added to denatured lysozyme. The absorbance decreased 
proportionally to the amount of Skp added as was shown by Entzminger et al.5 
Aggregation results in a heterogeneous population of monomers, dimers and trimmers. 
The standard error increased over time as the reaction progressed because the population 
of aggregates became more diverse.  
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Figure 2.6: Low levels of crowding reduce the aggregation of proteins, but high levels of 
crowding increase aggregation as shown in a lysozyme aggregation assay. 
Denatured lysozyme was added to solutions containing varying percentages 
of Ficoll 70 crowding agent. Low levels of crowding agent are expected to 
promote the folding of proteins and decrease aggregation, whereas high 
levels of crowding agent are expected to cause aggregation. The amount of 
absorbance, thus aggregation, over time decreased as concentrations of 
Ficoll increased up to 12.5%. The absorbance increased as concentrations of 
Ficoll increased from 12.5% to 20%. Low concentrations of Ficoll reduced 
aggregation as predicted, while high concentrations increased aggregation. 
The lysozyme aggregation assay was performed under in vivo-like conditions with 
varying percentages of Ficoll 70 but without Skp. A small amount of crowding promotes 
the folding of the substrate because the decrease in entropy is favored. Low 
concentrations of Ficoll are expected to increase the amount of folded protein and thus 
decrease the amount of aggregation. High concentrations of Ficoll are expected to cause 
aggregation. The amount of absorbance, thus aggregation, over time decreased as 
concentrations of Ficoll increased up to 12.5%. The absorbance increased as 
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concentrations of Ficoll increased from 12.5% to 20%. Low concentrations of Ficoll 
reduced aggregation as predicted, while high concentrations increased aggregation. These 
results confirmed the initial prediction. 
 
Figure 2.7: The effect of Skp on aggregation is diminished under in vivo-like conditions 
as compared to dilute in vitro experiments. Denatured lysozyme was diluted 
in solutions containing HBS or 7.5% ficoll with and without Skp (1µM). 
The greatest reduction in absorbance, and thus aggregation, resulted when 
Skp was added under dilute conditions. Skp reduced aggregation under 
crowded conditions. However, a reduction in aggregation was observed 
under in vivo-like conditions as compared to dilute in vitro experiments. 
The lysozyme aggregation assay was performed under in vivo-like conditions with 
varying percentages of Ficoll 70 and varying concentrations of Skp. Skp was shown to 
decrease aggregation in Figure 2.5. Also, low levels of Ficoll 70 were shown to decrease 
aggregation in Figure 2.6. The addition of Skp in the presence of low levels of Ficoll is 
expected to decrease aggregation. The addition of 0.25µM Skp in the presence of 7.5% 
Ficoll was observed to have higher aggregation than Skp without crowder as shown in 
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Figure 2.7. The prediction that Skp and low concentrations of Ficoll would decrease 
aggregation was incorrect. The effect of Skp on aggregation under in vivo-like conditions 
may be diminished as compared to in vitro results as the diffusion of Skp may be 
impeded in a crowded environment.  
CONCLUSIONS 
The effect of Skp on the aggregation of lysozyme in a crowded in vivo-like 
environment was observed. The lysozyme aggregation assay was performed under in 
vivo-like conditions with varying percentages of Ficoll 70. It was demonstrated that low 
concentrations of Ficoll reduced aggregation while high concentrations increased 
aggregation. The lysozyme aggregation assay was performed under in vivo-like 
conditions with varying percentages of Ficoll 70 with the addition of Skp. The effect of 
Skp on aggregation under in vivo-like conditions was diminished as compared to the 
effect of Skp in dilute in vitro conditions. This result may have occurred as the diffusion 
of Skp is decreased in a crowded environment. Further experiments observing the effect 
of Skp in varying concentrations of crowding agents would provide a sharper picture of 
Skp under in-vivo like conditions.  
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Chapter 3: Disulfide Bond Formation in the Periplasmic Space 
INTRODUCTION 
The order of interaction of Skp and the disulfide bond (dsb) formation system 
with substrate proteins has yet to be determined. Silhavy et al. investigated the order of 
interaction SurA, dsbA, and dsbC with lilpoprotein (LptD) in 2010.26 LptD is an outer 
integral membrane protein that is involved with the transfer of lipopolysaccharide to the 
outer leaflet of the outer membrane.26 LptD preferentially interacts preferentially with 
SurA and forms a complex with LptE.26 LptD contains two non-consecutive disulfide 
bonds.26 LptD is stable and can fold without disulfide bond formation.26 However, LptD 
cannot function unless one non-consecutive disulfide bond is correctly formed. These 
results suggest that LptD interact with SurA before the dsb system.26 A similar 
investigation into the order of interaction between Skp, DsbA and DsbC with substrate 
proteins has not occurred. Insights into the order of interaction of a second chaperone 
with DsbA and DsbC will comment on the larger discussion on protein folding. This 
knowledge will ultimately improve the production of soluble proteins.   
The order of interaction between Skp, DsbA and DsbC on a substrate protein was 
investigated. First, a lysozyme aggregation assay was performed with varying 
combinations of Skp, DsbA and DsbC. Skp and DsbA or DsbC is predicted to have the 
greatest effect in decreasing aggregation. The second experiment determined the order of 
interaction of Skp, DsbA, and DsbC with substrate protein. A lysozyme aggregation 
assay was performed under two conditions. In the first condition, DsbC was incubated 
with denatured lysozyme for 2 minutes, and then Skp was added. The absorbance at 
360nm was monitored over 30 minutes. In the second condition, Skp was incubated with 
lysozyme for two minutes, and then DsbC was added. The absorbance was again 
monitored at 360nm for 30 minutes. Determining the order of disulfide bond interaction 
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will inform the larger conversation on protein folding. Further experiments are needed to 
understand this interaction. 
MATERIALS AND METHODS 
Protein Purification 
Soluble DsbA and DsbC were expressed in the periplasmic space of E. coli using 
the same purification scheme as MBP in Chapter 2. The DsbA gene was previously 
cloned into a pAK400 plasmid with a n-terminal hexahistidine tag in BL21 (DE3) cells. 
DsbC was similarly cloned into a separate pAK400 plasmid in BL21 (DE3) cells. The 
eluted protein was purified in a second step through Superdex S75 or S200 size exclusion 
chromatography (SEC) columns operating on the AKTA FPLC system (GE Healthcare). 
The identify of the purified protein was characterized by 12% SDS-PAGE and the 
quantity of protein produced was determined by BCA Assay. 
Aggregation Assay 
The aggregation of lysozyme was replicated as in Chapter 2. In the first 
experiment in Figure 3.5 five HBS were assayed: HBS only, DsbC, DsbC with Skp, 
DsbA with Skp and DsbA. The absorbance at 360nm was detected at 10s intervals over 
30 minutes at room temperature with a SpectraMax M5.  
In the second experiment the aggregation assay was modified. This assay assessed 
the order of interaction between DsbC and Skp. Two experiments were tested. First, 
DsbC was added to denatured lysozyme and allowed to incubate for 2 minutes. Then, Skp 
was added. The absorbance at 360nm was detected at 10s intervals over 30 minutes at 
room temperature with a SpectraMax M5 immediately after the addition of Skp. 
Secondly, Skp was added to denatured lysozyme and allowed to incubate for 2 minutes. 
 27 
Then, DsbC was added. The absorbance at 360nm was detected at 10s intervals over 30 
minutes at room temperature immediately after the addition of DsbC.  
RESULTS 
The proteins used in subsequent experiments in this study had a high degree of 
purity as determined by size exclusion chromatography (SEC) and sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE). DsbA was expressed in the 
periplasmic space, purified first by IMAC chromatography and was purified next by 
SEC. DsbA exists as a monomer natively. The expected molecular weight of monomeric 
DsbA with a his-tag is estimated from the sequence to be 21,100 Da. A peak in the 
absorbance at 280nm is expected to occur between the Carbonic Anhyrdrase (29kDa, 
11.122mL) and Cytochrome C (12.4 kDa, 12.792mL) standard elution volumes. A peak 
was detected in this elution volume range as shown in Figure 3.1, confirming the identity 
of the produced protein. 
The purity of the protein was also confirmed by gel electrophoresis on a 12% 
SDS-Polyacrylamide gel as shown in Figure 3.2. A ladder (NEB Pre-stained Protein 
Marker, Broad Range) is shown in lane 4. The molecular weight of monomeric DsbA 
with a his tag is expected to be 23kDa. The protein samples in lanes 2,3 and 4-15 
migrated between the 17 and 25kDa markers. This further confirmed that DsbA was 
produced. A single band is observed in lane of protein samples indicating that the protein 
was pure. A BCA Assay confirmed that sufficient quantities of protein were produced in 
order to proceed. 
DsbC was expressed in the periplasmic space, purified first by IMAC 
chromatography and was purified next by SEC. DsbC is natively found as a dimer. The 
expected molecular weight of DsbC is estimated from the sequence to be 47,000 Da. A 
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peak in the absorbance at 280nm is expected to occur between the Albumin (66kDa, 
9.051mL) and Ovalbumin (44kDa, 9.633mL) standard elution volumes. A peak was 
detected in this elution volume range as shown in Figure 3.3, confirming the identity of 
the produced protein.  
The purity of the protein was also confirmed by gel electrophoresis on a 12% 
SDS-Polyacrylamide gel as shown in Figure 3.4. A ladder (NEB Pre-stained Protein 
Marker, Broad Range) is shown in lane 5. DsbC is a monomer under reducing conditions. 
The molecular weight of monomeric DsbC with his tag is expected to be 25kDa. The 
protein samples in lanes 2-4 and 6-15 migrated as far as the 25kDa marker. This further 
confirmed that DsbC was produced. A single band is observed in lane of protein samples 
indicating that the protein was pure. A BCA Assay confirmed that sufficient quantities of 
protein were produced in order to proceed. 
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Figure 3.1: DsbA was produced as shown by size exclusion chromatography on a GE 
Healthcare Superdex S75 column on the AKTA FPLC system. The 
molecular weight of monomeric DsbA is 21kDa. Monomeric DsbA eluted 
between 11.122-12.792mL. The peak corresponds to a total of 2.03mg of 
monomeric DsbA.  
 
Figure 3.2: Recombinant DsbA preparations exhibited a high degree of purity. Different 
fractions from a purification run are shown, separated on a 12% SDS-Poly 
Acrylamide Gel. Lanes reflect different fractions collected including the 
flowthrough from the IMAC column and those eluted off an S75 size 
exclusion chromatography column on an Akta FPLC. The molecular weight 
of monomeric DsbA with a his tag is expected to be 23kDa. The protein 
samples migrated as far as the 25kDa marker. This further confirmed that 
DsbA was produced. A single band is observed indicating that the 
preparations were pure. 
Lanes: 1. dsbA_Lysate	  2. dsbA_Flow	  through	  3. dsbA_A12	  4. Ladder	  5. dsbA_B12	  6. dsbA_B11	  7. dsbA_B10	  8. dsbA_B9	  9. dsbA_B8	  10. dsbA_B7	  11. dsbA_B6	  12. dsbA_B5	  13. dsbA_B4	  14. dsbA_B1	  15. dsbA_C1	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Figure 3.3: DsbC was produced as shown by size exclusion chromatography on a GE 
Healthcare Superdex S75 column on the AKTA FPLC system. The 
molecular weight of dimeric DsbC is 47kDa. Dimeric DsbC eluted between 
9.051-9.633mL. The peak corresponds to a total of 3.57mg of dimeric 
DsbC.  
 
Figure 3.4: Recombinant DsbC preparations exhibited a high degree of purity. Different 
fractions from a purification run are shown, separated on a 12% SDS-Poly 
Acrylamide Gel. Lanes reflect different fractions collected including the 
flowthrough from the IMAC column and those eluted off an S75 size 
exclusion chromatography column on an Akta FPLC. The molecular weight 
of monomeric DsbC with a his tag is 25kDA. The protein samples in lanes 
2-4, and 6-15 migrated as far as the 25kDa marker. This further confirmed 
that DsbC was produced. A single band is observed indicating that the 
preparations were pure. 
Lanes: 1. dsbC_Lysate	  2. dsbC_Flow	  through	  3. dsbC_A7	  4. dsbC_A8	  5. Ladder	  6. dsbC_A9	  7. dsbC_A10	  8. dsbC_A11	  9. dsbC_A12	  
Lanes: 10. dsbC_B12	  11. dsbC_B11	  12. dsbC_B10	  13. dsbC_B9	  14. dsbC_B8	  15. dsbC_B4	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Figure 3.5 Aggregation was reduced the most by the addition of DsbC as shown in this 
lysozyme aggregation assay. Denatured lysozyme was diluted in solutions 
containing HBS, DsbC, DsbC with Skp, DsbA with Skp and DsbA. The 
error bars show the standard deviation of three replicates.  
 First, the impact of Skp interacting with DsbA and DsbC was probed as shown in 
Figure 3.5. Denatured lysozyme was rapidly diluted into five different HBS solutions. 
The five conditions were HBS alone, DsbC, DsbC with Skp, DsbA with Skp and DsbA. 
The addition of Skp with either DsbA or DsbC is expected to reduce aggregation the 
most. The greatest reduction in the aggregation of lysozyme was due to the addition of 
Skp with either DsbA or DsbC. DsbC greatly reduced the absorbance, but not to the same 
level as Skp with either DsbA or DsbC. The isomerization of incorrectly paired disulfide 
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bonds reduces aggregation significantly. No decrease in absorbance was observed with 
the addition of DsbA. Protein aggregation is reduced primarily through Skp and DsbC.  
 
Figure 3.6 The order of interaction between DsbC and Skp as shown in a lysozyme 
aggregation assay. In the first reaction, DsbC was incubated with denatured 
lysozyme for two minutes then Skp was added and the absorbance was 
observed at 360nm for 30 minutes. In the second reaction, Skp was 
incubated with denatured lysozyme for two minutes then DsbC was added 
and the absorbance was observed at 360nm for 30 minutes. The trends are 
not statistically significant and further experimentation is needed to 
distinguish the order of interaction between Skp and DsbC.  
The order of interaction of Skp with DsbC was observed in Figure 3.6. In the first 
reaction, DsbC was incubated with denatured lysozyme for two minutes then Skp was 
added and the absorbance was observed at 360nm for 30 minutes. In the second reaction, 
Skp was incubated with denatured lysozyme for two minutes then DsbC was added and 
the absorbance was observed at 360nm for 30 minutes. The trends are not statistically 
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significant and further experimentation is needed to distinguish the order of interaction 
between Skp and DsbC.  
CONCLUSIONS 
The order of interaction of Skp, DsbA and DsbC with a substrate protein was 
investigated. In the first experiment, the effect of the combination of Skp with DsbA and 
Skp with DsbC on the aggregation of lysozyme was observed. The greatest reduction in 
the aggregation of lysozyme was due to the addition of Skp with either DsbA or DsbC. In 
the second experiment, the order of interaction between Skp, DsbA and DsbC was 
assayed. No clear conclusion could be drawn. Determining the order of disulfide bond 
interaction will inform the larger conversation on protein folding. The second experiment 
should be repeated in order to fully probe the order of interaction of Skp and DsbC.  
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